Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

TS03 Inc Trust Units TSTIF



GREY:TSTIF - Post by User

Post by echo2on May 10, 2016 12:07pm
239 Views
Post# 24858003

Turning on a Dime... EU and FDA Progress

Turning on a Dime... EU and FDA ProgressFor the skeptics and those selling into the shorts following the quarterly report ('buy the rumour, sell the news' retail investors)...

Read Rumble's CEO Message on the TSO3.com that was put out with the quarterly report last week:


"Another important milestone during the quarter was preparing for our launch in Europe later this year, which included Getinge exhibiting our STERIZONE® VP4 Sterilizer at its Infection Control meeting in France last April." This refers to a meeting last month in Lilles, France, I believe, the equivalent of the American sterilization meeting Rumble referred to during the Q&A recently in San Antonio where the VP4 was the 'Belle of the Ball'. I am still not sure why a press release was not made about this EU roll-out beginning with the exhibiting of the VP4 there, along with news that a pass-through unit is being designed for the EU market. 

And....


"TSO3 remains committed to bringing the highest level of care to the endoscopy suite with the pursuit of obtaining a cleared claim for complex, multi-channeled devices such as colonoscopes and gastroscopes. Our submission is in progress and we remain confident for timely and positive news." In other words, TSO3's response to FDA's questions about their extended claims this past quarter should be submitted any time now. TSO3 has in the past at least regarded such communications with the FDA as news worthy and has issued a press release when their response or clarified re-submission to the FDA is done. Here's hoping this happens today or tomorrow, or within the next week. :)) I am guessing this will be a positive for the stock price. :)

And, thanks, again, Lematou for your insights and links.

Thanks, too, to the weak hands selling to me at 2.07 - 2.09. You have no idea.... IMHO. :)





<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse